💨image loading
(from DailyMed)

Banana Boat Avobenzone, Homosalate, Octisalate, Octocrylene 9 g/100g; 4.5 g/100g; 6 g/100g; 2.7 g/100g Spray, 452 g — NDC 63354-078-39 (Billing 63354-0078-39)

by Edgewell Personal Care Brands, LLC · 452 g in 1 CAN

This is a package of 452 g of Banana Boat Avobenzone, Homosalate, Octisalate, Octocrylene 9 g/100g; 4.5 g/100g; 6 g/100g; 2.7 g/100g Spray from Edgewell Personal Care Brands, LLC, no longer marketed (first marketed Oct 2018), no longer in the FDA NDC Directory, this package's marketing ended Oct 2026.

NDC 63354-0078-39
🏷️ FDA NDC (as labeled) 63354-078-39 billing pads the product segment with a zero
This package
Contains452 g Pack sizes6 compare ↓
OTC Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 63354-078-39 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
63354 labeler · 078 product · 39 package
Package marketed since
Oct 15, 2018
Package marketing ended
Oct 1, 2026
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 6335407839 3
FDA record last changed
Aug 27, 2026
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Oct 2026. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 63354-078-39
Product NDC 63354-078
11-digit billing NDC 63354007839
UNII V06SV4M95S, 4X49Y0596W, 5A68WGF6WM, G63QQF2NOX
Application # M020
SPL Set ID 767a1504-1e02-1e06-e053-2a91aa0aa4b6
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Oct 2026)
Marketing start 2018-10-15
Marketing end 2026-10-01
Route TOPICAL
Dosage form SPRAY
Substance HOMOSALATE; OCTISALATE; OCTOCRYLENE; AVOBENZONE
Why two NDCs? The FDA registers this code as 63354-078-39 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 63354-0078-39. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Banana Boat Avobenzone, Homosalate, Octisalate, Octocrylene is a topical spray sunscreen marketed as an over-the-counter monograph product. It contains four UV-absorbing chemical filters, avobenzone, homosalate, octisalate, and octocrylene, which are commonly used together in sunscreen products to help absorb ultraviolet light. This spray formulation is typically applied to skin to provide sun protection. As an OTC monograph drug, it is marketed under established FDA guidelines for sunscreen ingredients rather than as an individually approved application.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 170 g 212 g 227 g 269 g 340 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
63354-0078-34 63354-078-34 Main listing 170 g in 1 CAN 2018-10-15 Oct 1, 2026 Discontinued by firm
63354-0078-35 63354-078-35 212 g in 1 CAN 2018-10-31 — Discontinued by firm
63354-0078-36 63354-078-36 227 g in 1 CAN 2018-10-15 Oct 1, 2026 Discontinued by firm
63354-0078-37 63354-078-37 269 g in 1 CAN 2018-10-15 Oct 1, 2026 Discontinued by firm
63354-0078-38 63354-078-38 340 g in 1 CAN 2018-10-15 Oct 1, 2026 Discontinued by firm
63354-0078-39 You're viewing this 452 g in 1 CAN 2018-10-15 Oct 1, 2026 Discontinued by firm

You're viewing the largest of 6 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This package contains 452 g — 452 g in 1 can.
How does this package differ from NDC 63354-0078-34?
Both are Banana Boat Avobenzone, Homosalate, Octisalate, Octocrylene 9 g/100g; 4.5 g/100g; 6 g/100g; 2.7 g/100g Spray — the drug itself is identical. This page's package is the 452 g one, while NDC 63354-0078-34 is the 170 g package.
What NDC number is used to bill for this package of Banana Boat Avobenzone, Homosalate, Octisalate, Octocrylene 9 g/100g; 4.5 g/100g; 6 g/100g; 2.7 g/100g Spray?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Banana Boat 9 g/100g; 4.5 g/100g; 6 g/100g; 2.7 g/100gthis 63354-0078-39 Edgewell 452 g — — Discontinued —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2018
On the market since
Oct 2018
📍
2026
Currently FDA-listed
8 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

We could not link this NDC to a current FDA Structured Product Label. An inactive-ingredient list is therefore not available from this source.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerEdgewell Personal Care Brands, LLC
FDA applicationM020 (OTC MONOGRAPH DRUG)
Labeler code63354
First marketedOct 2018
Product typeHuman Otc Drug
Portfolio28 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 33 words ▾

Uses • helps prevent sunburn • i f used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.

⏱️ Dosage and Administration 149 words ▾

Directions • Shake well . • hold container 4 to 6 inches from the skin to apply • spray liberally and spread evenly by hand 15 minutes before sun exposure • do not spray directly into face . Spray on hands then apply to face • do not apply in windy conditions • use in well-ventilated area • reapply: • after 80 minutes of swimming or sweating • immediately after towel drying • at least every 2 hours • Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging.

To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including: • limit time in the sun, especially from 10 a.m.–2 p.m. • wear long-sleeved shirts, pants, hats, and sunglasses • children under 6 months: Ask a doctor

⚠️ Warnings 124 words ▾

Warnings For external use only. Flammable: Contents under pressure. Do not puncture or incinerate.

Do not expose to heat or store at temperatures above 120°F. Do not use in the presence of a flame or spark. Keep away from sources of ignition – No smoking.

Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal. May stain some fabrics. Do not use on damaged or broken skin.

When using this product • Keep away from face to avoid breathing it • keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs.

Keep out of reach of children If product is swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 10 words ▾

Active Ingredient Avobenzone 2.7%, Homosalate 9%, Octisalate 4.5%, Octocrylene 6%

🧪 Inactive Ingredients 22 words ▾

Inactive Ingredients Alcohol Denat., Isobutane, Isododecane, Diisopropyl Adipate, VA/Butyl Maleate/Isobornyl Acrylate Copolymer, Caprylyl Glycol, Butyloctyl Salicylate, C12-15 Alkyl Benzoate, Fragrance, Tocopheryl Acetate.

🎯 Purpose 2 words ▾

Purpose Sunscreen

📄 Do Not Use 8 words ▾

Do not use on damaged or broken skin.

📄 When Using This Product 23 words ▾

When using this product • Keep away from face to avoid breathing it • keep out of eyes. Rinse with water to remove.

📄 Stop Use and Ask a Doctor If 9 words ▾

Stop use and ask a doctor if rash occurs.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children If product is swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 6 words ▾

Questions or comments? Call 1-800-SafeSun, Mon-Fri

📄 Package Label / Principal Display Panel ~1 min read ▾

BANANA BOAT® SPORT ultra CLEAR SUNSCREEN SPRAY BROAD SPECTRUM SPF 50+ 50+ CLINICALLY PROVEN UVA/UVB PROTECTION SUPERIOR ENDURANCE VS. SWEAT & WATER FREE FROM Oxybenzone Octinoxate Water Resistant (80 Minutes) NET WT 6 OZ. (170 g) BONUS 33% MORE 8 OZ VS 6 OZ BANANA BOAT® SPORT ultra CLEAR SUNSCREEN SPRAY BROAD SPECTRUM SPF 50+ 50+ CLINICALLY PROVEN UVA/UVB PROTECTION SUPERIOR ENDURANCE VS.

SWEAT & WATER FREE FROM Oxybenzone Octinoxate Water Resistant (80 Minutes) NET WT 8 OZ. (227 g) 55% MORE FAMILY SIZE! 9 OZ VS 6 OZ BANANA BOAT® SPORT ultra CLEAR SUNSCREEN SPRAY BROAD SPECTRUM SPF 50+ 50+ CLINICALLY PROVEN UVA/UVB PROTECTION SUPERIOR ENDURANCE VS.

SWEAT & WATER FREE FROM Oxybenzone Octinoxate Water Resistant (80 Minutes) NET WT

9.5OZ. (269 g) BUY 2 & SAVE! BANANA BOAT® SPORT ultra CLEAR SUNSCREEN SPRAY BROAD SPECTRUM SPF 50+ 50+ CLINICALLY PROVEN UVA/UVB PROTECTION SUPERIOR ENDURANCE VS.

SWEAT & WATER FREE FROM Oxybenzone Octinoxate Water Resistant (80 Minutes) 2 - 6 OZ. (170 g) CANS TOTAL NET WT. 12 OZ.

(340 g) BUY 2 & SAVE! BANANA BOAT® SPORT ultra CLEAR SUNSCREEN SPRAY BROAD SPECTRUM SPF 50+ 50+ CLINICALLY PROVEN UVA/UVB PROTECTION SUPERIOR ENDURANCE VS. SWEAT & WATER FREE FROM Oxybenzone Octinoxate Water Resistant (80 Minutes) 2- 8OZ.

(226g) CANS TOTAL NET WT. 16OZ. (452 g) Label Label Label Label Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Banana Boat (this brand).

Top reported reactions

Macular Degeneration460
Pyrexia307
Nausea290
Pain282
Malaise261
Weight Decreased236
Therapeutic Product Effect Incomplete214

Age at onset

Neonate5
Infant8
Child30
Adolescent8
Adult121
Elderly195

Reporter sex

2,003 reports
Male · 36%
Female · 64%
Unknown · 0%

Serious outcomes

Hospitalization998
Death207
Life-threatening117
Disabling32
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 284 86
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 5 other package presentations of this same product, including 170 g (63354-0078-34), 212 g (63354-0078-35), 227 g (63354-0078-36). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Edgewell Personal Care Brands, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.